| 89.23 -0.29 (-0.32%) | 08-18 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 107.66 | 1-year : | 125.75 |
| Resists | First : | 92.18 | Second : | 107.66 |
| Pivot price | 88.33  |
|||
| Supports | First : | 86.62 | Second : | 83.19 |
| MAs | MA(5) : | 89.87 |
MA(20) : | 87.5 |
| MA(100) : | 79.85 |
MA(250) : | 75.53 |
|
| MACD | MACD : | 1.4 |
Signal : | 1.4 |
| %K %D | K(14,3) : | 68.9 |
D(3) : | 72.9 |
| RSI | RSI(14): 59.9 |
|||
| 52-week | High : | 92.18 | Low : | 61.95 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ HSIC ] has closed below upper band by 36.7%. Bollinger Bands are 5.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 90.59 - 91.22 | 91.22 - 91.71 |
| Low: | 87.06 - 87.93 | 87.93 - 88.59 |
| Close: | 88.04 - 89.2 | 89.2 - 90.1 |
Henry Schein, Inc. (HSIC) is a global leader in delivering a comprehensive suite of healthcare products and services. The company caters to a diverse clientele across the globe, including dental professionals and laboratories, physician practices, governmental entities, and various institutional and alternative healthcare facilities. Its operations are organized into two principal segments: Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution division supplies an extensive array of dental goods, encompassing consumables (such as infection control items, impression materials, composites, anesthetics, and artificial teeth), specialized tools and equipment (like handpieces, dental chairs, delivery units, X-ray machinery, and advanced digital restoration systems), and personal protective equipment. This segment also provides essential equipment repair services. Furthermore, it distributes a broad range of medical supplies, including pharmaceuticals (both branded and generic), vaccines, surgical instruments, diagnostic kits, infection prevention solutions, imaging products, equipment, and nutritional supplements. The Technology and Value-Added Services segment focuses on empowering practices with advanced software, technology, and supplementary solutions. This includes specialized practice management software systems tailored for both dental and medical professionals. Beyond software, it delivers crucial value-added practice support services, such as non-recourse financial assistance, electronic services, comprehensive technology and network infrastructure support, hardware services, ongoing professional development programs, and expert consulting. Established in 1932, Henry Schein, Inc. maintains its corporate headquarters in Melville, New York.
Wed, 19 Aug 2026
Henry Schein (NASDAQ:HSIC) Stock Price Expected to Rise, BTIG Research Analyst Says - MarketBeat
Tue, 18 Aug 2026
HSIC Raises 2026 Outlook as Sales and Margin Momentum Accelerates - tradingview.com
Tue, 18 Aug 2026
Empowered Funds LLC Has $851,000 Position in Henry Schein, Inc. $HSIC - MarketBeat
Sun, 16 Aug 2026
How Henry Schein’s Strong Q2 Earnings and Higher 2026 Sales Outlook Will Impact Henry Schein (HSIC) Investors - simplywall.st
Fri, 14 Aug 2026
Henry Schein (HSIC) insider Bergman plans $3.18M sale under Form 144 - Stock Titan
Mon, 10 Aug 2026
Should Value Investors Buy Henry Schein (HSIC) Stock? - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Distribution
|
|
| Shares Out | 111 (M) |
| Shares Float | 91 (M) |
| Held by Insiders | 0.8 (%) |
| Held by Institutions | 109.8 (%) |
| Shares Short | 6,530 (K) |
| Shares Short P.Month | 7,680 (K) |
| EPS | 3.43 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 28.2 |
| Profit Margin | 2.9 % |
| Operating Margin | 5.7 % |
| Return on Assets (ttm) | 4.3 % |
| Return on Equity (ttm) | 8.8 % |
| Qtrly Rev. Growth | 6.6 % |
| Gross Profit (p.s.) | 38.22 |
| Sales Per Share | 122.02 |
| EBITDA (p.s.) | 9.69 |
| Qtrly Earnings Growth | 17.1 % |
| Operating Cash Flow | 700 (M) |
| Levered Free Cash Flow | 446 (M) |
| PE Ratio | 26.01 |
| PEG Ratio | 2 |
| Price to Book value | 3.16 |
| Price to Sales | 0.73 |
| Price to Cash Flow | 14.2 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|